A Agilent Technologies, Inc. Common Stock
Acerca de Agilent Technologies, Inc. Common Stock Descripción general de la empresa de Wikipedia
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
Leer más
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
From 1999 to 2014, the company produced optics (LED, laser), semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.
History
In 1965, Hewlett-Packard branched out into scientific equipment by acquiring F&M Scientific, maker of gas chromatographs. Agilent Technologies was created in 1999 as a spin-off of several business units of Hewlett-Packard including test & measurement, optics, instrumentation and chemical analysis, electronic components, and medical equipment product lines. The split was predicated on the difficulty of growing HP's revenue stream and on the competitive vigor of smaller, more agile competitors.
The company's launch slogan was "Innovating the HP Way", which capitalized on the strong HP corporate culture called The HP Way. The starburst logo was selected to reflect "a burst of insight" (or "spark of insight") and the name "Agilent" aimed to invoke the notion of agility as a trait of the new firm. The Agilent spin-off was accompanied by an initial public offering which raised $2.1 billion, setting a record at the time.
2000–2009
In the early 2000s, "economic uncertainty" depressed demand for Agilent's products, including slow sales of health care products to hospitals in the United States, which accounted for 60% of the company's revenue at the time. The downturn also struck sales in the communications and semiconductor markets, where orders amounting to $500 million were canceled by buyers. These poor economic conditions prompted large reductions in force with 18,500 positions cut in 2003.
In 2001, in midst of this downsizing, Agilent sold its health care and medical products organization to Philips Medical Systems, and was noted as having a valuation of about $11 billion. HP Medical Products had been the second oldest part of Hewlett-Packard, acquired in the 1950s.
In August 2005, Agilent announced the sale of its business which produced semiconductor integrated circuits (known as "chips") for consumer and industrial uses to Kohlberg Kravis Roberts and Silver Lake Partners for $2.66 billion. This move would involve termination of about 1,300 of the company's 28,000 employees. The group operated as a private company, Avago Technologies, until August 2009, when it was brought public in an IPO. After purchasing Broadcom Corporation in 2016, Avago changed its name to Broadcom Limited.
Also in August 2005, Agilent sold its 47% stake in the light-emitting diode manufacturer Lumileds to Philips for $1 billion. Lumileds originally started as Hewlett-Packard's optoelectronics division. Also in August 2005, Agilent announced a plan to divest its semiconductor test business, composed of both the system-on-chip and memory test market areas. Agilent listed the new company as Verigy on the Nasdaq in mid-2006.
2010 onwards
In 2009, Agilent announced the closure of a subsection of its Test & Measurement division. The product lines affected included the automated optical inspection, solder paste inspection, and automated X-ray products [5DX] in 2004. In 2011, the company, along with the University of California, Davis, announced that it would be establishing the "Davis Millimeter Wave Research Center". Agilent announced it would increase its life sciences engagement through the acquisition of Halo Genomics, based in Uppsala, Sweden, which was involved in next-generation sequencing technology development. On May 17, 2012, Agilent agreed to buy Dako, a Danish cancer diagnostics company, for $2.2 billion, to expand its presence in the life sciences industry.
On September 19, 2013, Agilent announced its decision to separate into two publicly traded companies: Agilent, a life sciences, diagnostics, and applied markets company, and Keysight, an electronic measurement company. The life sciences company retained the Agilent name and the electronic measurement company was called Keysight Technologies. On October 14, 2014, the company announced that it is exiting its Nuclear Magnetic Resonance business. On November 1, the formal separation of Agilent and Keysight Technologies was completed. Agilent announced it had completed the spin-off of its electronic measurement business, Keysight Technologies.
In September 2015, the company announced it would acquire Seahorse Bioscience for $235 million. On July 7, 2016, Agilent announced that it had acquired U.K. based Cobalt Light Systems, which develops and manufactures Raman spectroscopy instruments, for £40 million in cash. In December the company acquired Multiplicom N.V.
In January 2018, the company announced it would acquire Luxcel Biosciences, increasing the company's cell analysis portfolio. In May, Agilent acquired Lasergen, Inc. after the end of its two-year option on a prior investment. In the same month it acquired digital laboratory management company, Genohm, Ultra Scientific, provider of chemical standards and reference materials and Advanced Analytical Technologies, Inc. (AATI), provider of capillary electrophoresis-based molecules for $250 million in cash.
In August the company announced it would acquire glycan reagent producer, ProZyme, Inc. and South Korean instrument distributor, Young In Scientific Co. Ltd. In September Agilent acquired ACEA Biosciences for $250 million increasing the company's presence in cell analysis technologies. In August 2019, Agilent acquired US-based BioTek Instruments, a designer, manufacturer, and distributor of life science instrumentation, for $1.165 billion. On May 1, 2024, Padraig McDonnell succeeded Mike McMullen as CEO.
Products and services
Agilent serves analytical laboratories and the clinical and routine diagnostics markets with a full suite of technology platforms. These include: automation, bioreagents, FISH probes, gas and liquid chromatography, immunohistochemistry, informatics, mass spectrometry, microarrays, spectroscopy, target enrichment, and vacuum technologies.
Agilent also provides lab management services, including enterprise asset management, laboratory business intelligence, equipment management and service, software maintenance, regulatory compliance, sample preparation, genomics and cloning, GC and HPLC columns, spectrometry and spectroscopy supplies, and consumables. The company is known for investing in R&D within its own research labs and those of leading universities to advance the state of knowledge in the life sciences, diagnostics, and chemical analysis space.
In recent years, the company has advanced digital lab instrumentation and technology that improves lab workflow and overall efficiency and productivity. In 2020, Agilent introduced CrossLab Virtual Assist, a mobile app that facilities high-quality remote technical support. Agilent's digital advancements, including CrossLab Connect, have also improved lab optimization and sustainability by providing more efficient utilization of instruments, which can lower a lab's energy consumption.
Agilent is also a pioneer of the target enrichment used as part of a NGS workflow. The portfolio also includes sample prep, QA/QC instrumentation, 2100 bioanalyzers, and automation tools. In early 2023, the company announced a $725 million expansion of its nucleic acid-based therapeutics manufacturing facility in Frederick, Colorado.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
A Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
A Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto |
|---|---|
| 30 de junio de 2026 | $0,2550 |
| 31 de marzo de 2026 | $0,2550 |
| 6 de enero de 2026 | $0,2550 |
| 30 de septiembre de 2025 | $0,2480 |
| 1 de julio de 2025 | $0,2480 |
| 1 de abril de 2025 | $0,2480 |
| 31 de diciembre de 2024 | $0,2480 |
| 1 de octubre de 2024 | $0,2360 |
| 2 de julio de 2024 | $0,2360 |
| 1 de abril de 2024 | $0,2360 |
| 29 de diciembre de 2023 | $0,2360 |
| 2 de octubre de 2023 | $0,2250 |
| 30 de junio de 2023 | $0,2250 |
| 3 de abril de 2023 | $0,2250 |
| 30 de diciembre de 2022 | $0,2250 |
| 3 de octubre de 2022 | $0,2100 |
| 1 de julio de 2022 | $0,2100 |
| 4 de abril de 2022 | $0,2100 |
| 3 de enero de 2022 | $0,2100 |
| 4 de octubre de 2021 | $0,1940 |
A Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 8 27,6%
- Compra 14 48,3%
- Mantener 7 24,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
19 analistas · 2026-08-19Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $1.49 | $1.44 | 0.05% |
| 31 de marzo de 2026 | $1.36 | $1.40 | -0.04% |
| 31 de diciembre de 2025 | $1.59 | $1.62 | -0.03% |
| 30 de septiembre de 2025 | $1.37 | $1.39 | -0.02% |
| 30 de junio de 2025 | $1.31 | $1.29 | 0.02% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | · | $4.47B | $4.20B | $4.04B | |
| Cost of Revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B | $2.50B | $2.36B | · | $2.07B | $2.00B | $2.00B | |
| R&D Expense | $455M | $479M | $481M | $467M | $441M | $495M | $404M | · | $341M | $329M | $330M | |
| SG&A Expense | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B | $1.50B | $1.46B | · | $1.25B | $1.25B | $1.19B | |
| Operating Expenses | $5.47B | $5.02B | $5.48B | $5.23B | $4.97B | $4.49B | $4.22B | · | $3.67B | $3.59B | $3.52B | |
| Operating Income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B | $846M | $941M | · | $807M | $615M | $522M | |
| Interest Expense | $112M | $96M | $95M | $84M | $81M | $78M | $74M | · | $79M | $72M | $66M | |
| Interest Income | $62M | $80M | $51M | $9M | $2M | $8M | $36M | · | $22M | $11M | $7M | |
| Other Non-op | $6M | $49M | $33M | $-39M | $92M | $66M | $16M | · | $53M | $-10M | $17M | |
| Pretax Income | $1.44B | $1.52B | $1.34B | $1.50B | $1.36B | $842M | $919M | · | $803M | $544M | $767M | |
| Income Tax | $132M | $232M | $99M | $250M | $150M | $123M | $-152M | · | $119M | $82M | $42M | |
| Net Income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719M | $1.07B | · | $684M | $462M | $401M | |
| EPS (Basic) | $4.59 | $4.44 | $4.22 | $4.19 | $3.98 | $2.33 | $3.41 | · | $2.12 | $1.42 | $1.20 | |
| EPS (Diluted) | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | · | $2.10 | $1.40 | $1.20 | |
| Shares (Basic) | 284,000,000 | 290,000,000 | 294,000,000 | 299,000,000 | 304,000,000 | 309,000,000 | 314,000,000 | · | 322,000,000 | 326,000,000 | 333,000,000 | |
| Shares (Diluted) | 285,000,000 | 291,000,000 | 296,000,000 | 300,000,000 | 307,000,000 | 312,000,000 | 318,000,000 | · | 326,000,000 | 329,000,000 | 335,000,000 | |
| EBITDA | $1.77B | $1.75B | $1.62B | $1.94B | $1.67B | $1.15B | $1.18B | · | $1.05B | $861M | $775M |
Balance general 29
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.79B | $1.33B | $1.59B | $1.05B | $1.48B | $1.44B | $1.38B | $2.25B | $2.68B | $2.29B | $2.00B | |
| Receivables | $1.49B | $1.32B | $1.29B | $1.41B | $1.17B | $1.04B | $930M | $800M | $724M | $631M | $606M | |
| Inventory | $1.02B | $972M | $1.03B | $1.04B | $830M | $720M | $679M | $628M | $575M | $533M | $541M | |
| Other Current Assets | $293M | $334M | $274M | $282M | $222M | $216M | $198M | $190M | $192M | $182M | $294M | |
| Current Assets | $4.59B | $3.96B | $4.19B | $3.78B | $3.80B | $3.42B | $3.19B | $3.87B | $4.17B | $3.63B | $3.69B | |
| PP&E (Net) | $2.02B | $1.78B | $1.27B | $1.10B | $945M | $845M | $850M | $822M | $757M | $639M | $604M | |
| PP&E (Gross) | $3.45B | $3.08B | $2.49B | $2.25B | $2.07B | $1.87B | $1.77B | · | $1.60B | $1.41B | $1.33B | |
| Accum. Depreciation | $1.42B | $1.30B | $1.22B | $1.15B | $1.12B | $1.03B | $925M | · | $843M | $767M | $730M | |
| Goodwill | $4.47B | $4.48B | $3.96B | $3.95B | $3.98B | $3.60B | $3.59B | $2.97B | $2.61B | $2.52B | $2.37B | |
| Intangibles | $445M | $547M | $475M | $821M | $981M | $831M | $1.11B | $491M | $361M | $416M | $445M | |
| Other Non-current Assets | $1.06B | $910M | $708M | $686M | $820M | $776M | $611M | $332M | $394M | $452M | $292M | |
| Total Assets | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.56B | $8.43B | $7.79B | $7.48B | |
| Accounts Payable | $570M | $540M | $418M | $580M | $446M | $354M | $354M | $340M | $305M | $257M | $279M | |
| Short-term Debt | $304M | $45M | $0 | $36M | $0 | $75M | $616M | · | $210M | $0 | $0 | |
| Current Liabilities | $2.35B | $1.90B | $1.60B | $1.86B | $1.71B | $1.47B | $2.08B | $1.16B | $1.26B | $945M | $976M | |
| Capital Leases | $145M | $142M | $118M | $101M | $130M | $127M | $5M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $31M | · | $77M | $65M | $96M | |
| Other Non-current Liabilities | $463M | $578M | $477M | $536M | $659M | $614M | $473M | $763M | $293M | $339M | $414M | |
| Total Liabilities | $5.99B | $5.95B | $4.92B | $5.23B | $5.32B | $4.75B | $4.70B | $3.96B | $3.59B | $3.55B | $3.31B | |
| Long-term Debt | $3.05B | $3.35B | $2.73B | $2.73B | $2.73B | $2.28B | $1.79B | · | $1.79B | $1.89B | $1.60B | |
| Total Debt | $304M | $45M | $0 | $36M | $2.73B | $2.36B | $2.41B | · | $2.01B | $1.91B | $1.66B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $6M | $6M | |
| Paid-in Capital | $5.58B | $5.45B | $5.39B | $5.33B | $5.32B | $5.31B | $5.28B | $5.31B | $5.30B | $9.16B | $9.04B | |
| Retained Earnings | $1.39B | $750M | $782M | $324M | $348M | $81M | $-18M | $-303M | $-126M | $6.09B | $5.58B | |
| Treasury Stock | · | · | · | · | · | · | · | · | $0 | $10.51B | $10.07B | |
| AOCI | $-226M | $-305M | $-327M | $-347M | $-282M | $-522M | $-514M | $-415M | $-346M | $-503M | $-391M | |
| Stockholders' Equity | $6.74B | $5.90B | $5.84B | $5.30B | $5.39B | $4.87B | $4.75B | $4.59B | $4.83B | $4.24B | $4.17B | |
| Liabilities + Equity | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.56B | $8.43B | $7.79B | $7.48B | |
| Shares Outstanding | 283,054,377 | 285,193,011 | 292,123,241 | 295,259,092 | 302,000,000 | 306,000,000 | 309,000,000 | · | 322,000,000 | 614,000,000 | 611,000,000 |
Flujo de Efectivo 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $288M | $257M | $271M | $317M | $321M | $308M | $238M | · | $212M | $246M | $253M | |
| Stock-based Comp | $128M | $129M | $111M | $125M | $110M | $83M | $72M | · | $60M | $58M | $54M | |
| Deferred Tax | $-130M | $-64M | $-56M | $8M | $14M | $29M | $-255M | · | $102M | $3M | $70M | |
| Amort. of Intangibles | $105M | $105M | $140M | $192M | $195M | $186M | $128M | · | $120M | $154M | $158M | |
| Restructuring | $82M | $76M | $46M | · | · | · | · | · | · | · | $6M | |
| Other Non-cash | $-30M | $140M | $206M | $-392M | $-170M | $-218M | $-105M | · | $-169M | $24M | $-287M | |
| Operating Cash Flow | $1.56B | $1.75B | $1.77B | $1.31B | $1.49B | $921M | $1.02B | · | $889M | $793M | $512M | |
| CapEx | $407M | $378M | $298M | $291M | $188M | $119M | $155M | · | $176M | $139M | $98M | |
| Investing Cash Flow | $-394M | $-1.26B | $-310M | $-338M | $-749M | $-147M | $-1.59B | · | $-304M | $-238M | $-400M | |
| Debt Issued | $4M | $1.20B | $0 | $600M | $848M | · | · | · | · | · | · | |
| Net Debt Issued | $1M | $597M | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $425M | $1.15B | $575M | $1.14B | $788M | $469M | $723M | · | $194M | $434M | $267M | |
| Net Stock Activity | $-425M | $-1.15B | $-575M | $-1.14B | $-788M | $-469M | $-723M | · | $-194M | $-434M | $-267M | |
| Dividends Paid | $282M | $274M | $265M | $250M | $236M | $222M | $206M | · | $170M | $150M | $133M | |
| Financing Cash Flow | $-715M | $-752M | $-930M | $-1.37B | $-696M | $-717M | $-299M | · | $-202M | $-268M | $-1.09B | |
| Net Change in Cash | $459M | $-261M | $537M | $-434M | $43M | $59M | $-866M | · | $391M | $286M | $-1.02B | |
| Taxes Paid | $318M | $314M | $199M | $279M | $211M | $361M | $159M | · | · | · | · | |
| Free Cash Flow | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B | $802M | $866M | · | $713M | $654M | $393M | |
| Levered FCF | $1.05B | $1.29B | $1.39B | $951M | $1.22B | $735M | $780M | · | $644M | $589M | $331M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% | 15.8% | 18.2% | · | 18.8% | 14.6% | 12.9% | |
| Net Margin | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% | 20.7% | · | 15.3% | 11.0% | 9.9% | |
| Pretax Margin | 20.6% | 23.4% | 19.6% | 22.0% | 21.5% | 15.8% | 17.8% | · | 21.8% | 20.4% | 19.0% | |
| EBITDA Margin | 25.4% | 26.8% | 23.7% | 28.3% | 26.4% | 21.6% | 22.8% | · | 23.5% | 20.5% | 19.2% | |
| ROA | 10.6% | 11.4% | 11.7% | 11.8% | 11.9% | 7.5% | 11.9% | · | 8.4% | 6.0% | 4.4% | |
| ROE | 20.6% | 21.9% | 22.2% | 23.4% | 23.6% | 14.9% | 22.9% | · | 15.1% | 11.0% | 8.5% | |
| ROIC | 19.1% | 21.2% | 21.4% | 25.3% | 14.8% | 10.0% | 15.3% | · | 10.8% | 9.0% | 8.5% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.1 | 2.6 | 2.0 | 2.2 | 2.3 | 1.5 | · | 3.3 | 3.8 | 3.8 | |
| Quick Ratio | 1.4 | 1.4 | 1.8 | 1.3 | 1.6 | 1.7 | 1.1 | · | 2.7 | 3.1 | 2.7 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | |
| LT Debt / Equity | · | · | · | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | |
| Interest Coverage | 13.2 | 15.5 | 14.2 | 19.3 | 16.6 | 10.8 | 12.7 | · | 10.6 | 8.5 | 7.9 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.4 | |
| Inventory Turnover | 3.3 | 3.0 | 3.3 | 3.3 | 3.8 | 3.6 | 3.6 | · | 3.7 | 3.7 | 3.6 | |
| Receivables Turnover | 4.9 | 5.0 | 5.1 | 5.3 | 5.7 | 5.4 | 6.0 | · | 6.6 | 6.8 | 6.6 |
Tasas de Crecimiento 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.7% | -4.7% | -0.22% | 8.4% | 18.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.48% | 1.0% | 8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 3.2% | 5.7% | 0.24% | 6.1% | 71.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.0% | 4.0% | 22.1% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 14.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1.1% | 4.0% | -1.1% | 3.6% | 68.3% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.3% | 2.1% | 19.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | · | $4.47B | $4.20B | $4.04B | |
| Net Income TTM | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719M | $1.07B | · | $684M | $462M | $401M | |
| Market Cap | $41.43B | $37.16B | $30.20B | $40.81B | $47.56B | $31.24B | · | · | · | · | · | |
| Enterprise Value | $39.94B | $35.88B | $28.61B | $39.80B | $48.81B | $32.16B | · | · | · | · | · | |
| P/E | 32.0 | 29.4 | 24.7 | 33.1 | 40.0 | 44.4 | 22.5 | · | 32.4 | 31.1 | 31.5 | |
| P/S | 6.0 | 5.7 | 4.4 | 6.0 | 7.5 | 5.9 | · | · | · | · | · | |
| P/B | 6.1 | 6.3 | 5.2 | 7.7 | 8.8 | 6.4 | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 42.5 | 21.4 | 76.7 | 109.8 | 71.0 | · | · | · | · | · | |
| P / Cash Flow | 26.6 | 21.2 | 17.0 | 31.1 | 32.0 | 33.9 | · | · | · | · | · | |
| P / FCF | 36.0 | 27.1 | 20.5 | 40.0 | 36.7 | 39.0 | · | · | · | · | · | |
| EV / EBITDA | 22.6 | 20.6 | 17.6 | 20.6 | 29.3 | 27.9 | · | · | · | · | · | |
| EV / FCF | 34.7 | 26.1 | 19.4 | 39.0 | 37.6 | 40.1 | · | · | · | · | · | |
| EV / Revenue | 5.7 | 5.5 | 4.2 | 5.8 | 7.7 | 6.0 | · | · | · | · | · | |
| Dividend Yield | 0.68% | 0.74% | 0.88% | 0.61% | 0.50% | 0.71% | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.4% | 4.0% | 3.0% | 2.5% | 2.2% | 4.5% | · | 3.1% | 3.2% | 3.2% | |
| Payout Ratio | 21.6% | 21.3% | 21.4% | 19.9% | 19.5% | 30.9% | 19.2% | · | 24.9% | 32.5% | 33.2% | |
| Annual Payout | $282M | $274M | $265M | $250M | $236M | $222M | $206M | · | $170M | $150M | $133M |
Estado de resultados 17
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83B | $1.80B | $1.86B | $1.74B | $1.67B | $1.68B | $1.70B | $1.58B | $1.57B | $1.66B | $1.69B | $1.67B | $1.72B | $1.76B | $1.85B | $1.72B | |
| Cost of Revenue | $845M | $852M | $871M | $850M | $802M | $782M | $785M | $723M | $717M | $750M | $773M | $1.01B | $793M | $788M | $837M | $779M | |
| R&D Expense | $126M | $117M | $119M | $111M | $112M | $113M | $111M | $127M | $113M | $128M | $114M | $118M | $126M | $123M | $119M | $116M | |
| SG&A Expense | $465M | $476M | $428M | $417M | $454M | $410M | $397M | $395M | $380M | $396M | $393M | $407M | $415M | $419M | $422M | $412M | |
| Operating Expenses | $1.44B | $1.45B | $1.42B | $1.38B | $1.37B | $1.30B | $1.29B | $1.25B | $1.21B | $1.27B | $1.28B | $1.54B | $1.33B | $1.33B | $1.38B | $1.31B | |
| Operating Income | $399M | $353M | $443M | $360M | $300M | $376M | $408M | $333M | $363M | $384M | $408M | $133M | $383M | $426M | $471M | $411M | |
| Interest Expense | $25M | $25M | $27M | $28M | $29M | $28M | $32M | $22M | $20M | $22M | $22M | $24M | $24M | $25M | $23M | $19M | |
| Interest Income | $13M | $15M | $17M | $16M | $14M | $15M | $24M | $19M | $19M | $18M | $17M | $13M | $12M | $9M | $5M | $2M | |
| Other Non-op | $21M | $21M | $9M | $18M | $-25M | $4M | $1M | $13M | $12M | $23M | $17M | $10M | $6M | $0 | $2M | $3M | |
| Pretax Income | $408M | $364M | $442M | $366M | $260M | $367M | $401M | $343M | $374M | $403M | $420M | $132M | $377M | $410M | $455M | $397M | |
| Income Tax | $69M | $59M | $8M | $30M | $45M | $49M | $50M | $61M | $66M | $55M | $-55M | $21M | $75M | $58M | $87M | $68M | |
| Net Income | $339M | $305M | $434M | $336M | $215M | $318M | $351M | $282M | $308M | $348M | $475M | $111M | $302M | $352M | $368M | $329M | |
| EPS (Basic) | $1.20 | $1.08 | $1.54 | $1.18 | $0.75 | $1.12 | $1.23 | $0.97 | $1.05 | $1.19 | $1.63 | $0.38 | $1.02 | $1.19 | $1.23 | $1.10 | |
| EPS (Diluted) | $1.20 | $1.07 | $1.53 | $1.18 | $0.75 | $1.11 | $1.23 | $0.97 | $1.05 | $1.18 | $1.60 | $0.38 | $1.02 | $1.19 | $1.24 | $1.10 | |
| Shares (Basic) | 282,000,000 | 283,000,000 | -570,000,000 | 284,000,000 | 285,000,000 | 285,000,000 | -586,000,000 | 290,000,000 | 293,000,000 | 293,000,000 | -592,000,000 | 294,000,000 | 296,000,000 | 296,000,000 | -599,000,000 | 298,000,000 | |
| Shares (Diluted) | 283,000,000 | 284,000,000 | -572,000,000 | 285,000,000 | 285,000,000 | 287,000,000 | -587,000,000 | 291,000,000 | 293,000,000 | 294,000,000 | -593,000,000 | 295,000,000 | 297,000,000 | 297,000,000 | -603,000,000 | 299,000,000 | |
| EBITDA | $399M | $420M | · | $360M | $300M | $448M | · | $333M | $363M | $446M | · | $133M | $383M | $493M | · | $411M |
Balance general 27
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B | $1.67B | $1.75B | $1.59B | $1.33B | $1.18B | $1.25B | $1.05B | $1.07B | |
| Receivables | $1.50B | $1.52B | $1.49B | $1.38B | $1.37B | $1.33B | $1.32B | $1.23B | $1.25B | $1.29B | · | $1.34B | $1.40B | $1.46B | · | $1.34B | |
| Inventory | $1.09B | $1.06B | $1.02B | $1.01B | $991M | $997M | $972M | $978M | $1.00B | $1.03B | · | $1.07B | $1.10B | $1.11B | · | $1.01B | |
| Other Current Assets | $369M | $277M | $293M | $322M | $365M | $315M | $334M | $272M | $283M | $262M | · | $290M | $270M | $258M | · | $258M | |
| Current Assets | $4.76B | $4.62B | $4.59B | $4.25B | $4.21B | $4.11B | $3.96B | $4.26B | $4.20B | $4.34B | · | $4.03B | $3.95B | $4.08B | · | $3.69B | |
| PP&E (Net) | $2.10B | $2.08B | $2.02B | $1.97B | $1.91B | $1.82B | $1.78B | $1.45B | $1.37B | $1.31B | · | $1.21B | $1.18B | $1.15B | · | $1.05B | |
| PP&E (Gross) | · | · | $3.45B | · | · | · | $3.08B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.42B | · | · | · | $1.30B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $4.48B | $4.48B | $4.47B | $4.47B | $4.47B | $4.43B | $4.48B | $3.96B | $3.96B | $3.97B | $3.96B | $3.98B | $3.98B | $3.98B | $3.95B | $3.95B | |
| Intangibles | $407M | $426M | $445M | $469M | $495M | $514M | $547M | $392M | $417M | $443M | · | $502M | $798M | $810M | · | $849M | |
| Other Non-current Assets | $1.18B | $1.07B | $1.06B | $930M | $934M | $875M | $910M | $751M | $725M | $716M | · | $758M | $695M | $713M | · | $749M | |
| Total Assets | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | · | $10.68B | $10.79B | $10.92B | · | $10.48B | |
| Accounts Payable | $615M | $602M | $570M | $530M | $517M | $547M | $540M | $497M | $461M | $488M | · | $452M | $479M | $540M | · | $558M | |
| Short-term Debt | $304M | $304M | $304M | $59M | $146M | $16M | $45M | $795M | $420M | · | · | $55M | $0 | $238M | · | $180M | |
| Current Liabilities | $2.27B | $2.23B | $2.35B | $1.89B | $2.01B | $1.87B | $1.90B | $2.39B | $1.96B | $1.62B | · | $1.76B | $1.67B | $1.94B | · | $1.90B | |
| Capital Leases | · | · | $145M | · | · | · | $142M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $496M | $491M | $463M | $495M | $535M | $551M | $578M | $471M | $449M | $486M | · | $531M | $515M | $542M | · | $583M | |
| Total Liabilities | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B | $4.64B | $4.76B | · | $5.12B | $5.01B | $5.31B | · | $5.39B | |
| Long-term Debt | $3.05B | $3.05B | $3.05B | $3.35B | $3.35B | $3.35B | $3.35B | $2.14B | $2.14B | $2.56B | · | $2.73B | $2.73B | $2.73B | · | $2.73B | |
| Total Debt | $304M | $304M | · | $59M | $146M | $16M | · | $795M | $420M | · | · | $55M | $0 | $238M | · | $180M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Paid-in Capital | $5.63B | $5.61B | $5.58B | $5.55B | $5.50B | $5.49B | $5.45B | $5.46B | $5.46B | $5.44B | · | $5.38B | $5.36B | $5.34B | · | $5.31B | |
| Retained Earnings | $1.69B | $1.48B | $1.39B | $1.10B | $912M | $916M | $750M | $773M | $1.09B | $1.06B | · | $444M | $700M | $541M | · | $139M | |
| AOCI | $-202M | $-184M | $-226M | $-283M | $-280M | $-381M | $-305M | $-331M | $-337M | $-316M | · | $-271M | $-282M | $-280M | $-347M | $-362M | |
| Stockholders' Equity | $7.12B | $6.91B | $6.74B | $6.37B | $6.14B | $6.03B | $5.90B | $5.90B | $6.21B | $6.19B | · | $5.56B | $5.78B | $5.61B | · | $5.09B | |
| Liabilities + Equity | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | · | $10.68B | $10.79B | $10.92B | · | $10.48B | |
| Shares Outstanding | 282,218,158 | 282,695,763 | 283,054,377 | 283,593,838 | 283,936,028 | 285,232,190 | 285,193,011 | 287,529,636 | 291,587,707 | 293,041,817 | · | 293,000,000 | 295,000,000 | 296,000,000 | · | 296,000,000 |
Flujo de Efectivo 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $71M | $72M | $73M | $72M | $69M | $63M | $63M | $62M | $62M | $71M | $71M | $67M | $73M | $80M | |
| Stock-based Comp | $32M | $41M | $26M | $32M | $30M | $40M | $26M | $28M | $31M | $44M | $14M | $29M | $24M | $44M | $26M | $28M | |
| Deferred Tax | $32M | $25M | $-95M | $-7M | $-18M | $-10M | $-56M | $-1M | $-7M | $0 | $13M | $-68M | $-5M | $4M | $-17M | $6M | |
| Amort. of Intangibles | $19M | $19M | $24M | $26M | $27M | $28M | $27M | $25M | $27M | $26M | $27M | $39M | $38M | $36M | $42M | $48M | |
| Restructuring | $8M | $20M | $8M | $17M | $56M | $1M | $5M | $67M | $1M | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-170M | · | · | · | $11M | · | · | · | $31M | · | · | · | $-171M | · | · | |
| Operating Cash Flow | $277M | $268M | $545M | $362M | $221M | $431M | $481M | $452M | $333M | $485M | $516M | $562M | $398M | $296M | $448M | $326M | |
| CapEx | $76M | $93M | $93M | $103M | $114M | $97M | $93M | $92M | $103M | $90M | $84M | $81M | $57M | $76M | $70M | $82M | |
| Investing Cash Flow | $-77M | $-93M | $-90M | $-96M | $-114M | $-94M | $-954M | $-100M | $-109M | $-95M | $-40M | $-89M | $-77M | $-104M | $-110M | $-73M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $4M | $1.20B | $0 | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Debt Issued | · | $-2M | · | · | · | $3M | · | · | · | $-180M | · | · | · | · | · | · | |
| Stock Repurchased | $65M | $152M | $85M | $85M | $165M | $90M | $335M | $585M | $230M | $0 | $80M | $335M | $85M | $75M | $135M | $323M | |
| Net Stock Activity | · | $-152M | · | · | · | $-90M | · | · | · | $0 | · | · | · | $-75M | · | · | |
| Dividends Paid | $72M | $72M | $70M | $71M | $70M | $71M | $68M | $68M | $69M | $69M | $66M | $66M | $66M | $67M | $62M | $62M | |
| Financing Cash Flow | $-144M | $-222M | $-200M | $-219M | $-116M | $-180M | $25M | $-246M | $-291M | $-240M | $-201M | $-322M | $-390M | $-17M | $-341M | $-362M | |
| Net Change in Cash | $49M | $-31M | $254M | $48M | $19M | $138M | $-450M | $108M | $-76M | $157M | $261M | $154M | $-75M | $197M | $-17M | $-115M | |
| Taxes Paid | $215M | $105M | $14M | $56M | $229M | $19M | $30M | $60M | $200M | $24M | $56M | $15M | $111M | $17M | $62M | $83M | |
| Free Cash Flow | · | $175M | · | · | · | $334M | · | · | · | $395M | · | · | · | $220M | · | · | |
| Levered FCF | · | $154M | · | · | · | $310M | · | · | · | $376M | · | · | · | $199M | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 21.7% | 19.6% | · | 20.7% | 18.0% | 22.4% | · | 21.1% | 23.1% | 23.2% | · | 8.0% | 22.3% | 24.3% | · | 23.9% | |
| Net Margin | 18.5% | 17.0% | · | 19.3% | 12.9% | 18.9% | · | 17.9% | 19.6% | 21.0% | · | 6.6% | 17.6% | 20.1% | · | 19.1% | |
| Pretax Margin | 22.2% | 20.2% | · | 21.1% | 15.6% | 21.8% | · | 21.7% | 23.8% | 24.3% | · | 7.9% | 22.0% | 23.4% | · | 23.1% | |
| EBITDA Margin | 21.7% | 23.4% | · | 20.7% | 18.0% | 26.7% | · | 21.1% | 23.1% | 26.9% | · | 8.0% | 22.3% | 28.1% | · | 23.9% | |
| ROA | 2.7% | 2.5% | · | 2.9% | 1.9% | 2.8% | · | 2.6% | 2.9% | 3.2% | · | 1.1% | 2.8% | 3.3% | · | 3.1% | |
| ROE | 5.1% | 4.7% | · | 5.5% | 3.5% | 5.2% | · | 4.9% | 5.1% | 5.9% | · | 2.1% | 5.5% | 6.5% | · | 6.6% | |
| ROIC | 4.5% | 4.1% | · | 5.1% | 4.0% | 5.4% | · | 4.1% | 4.5% | 5.4% | · | 2.0% | 5.3% | 6.3% | · | 6.5% |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.1 | · | 2.2 | 2.1 | 2.2 | · | 1.8 | 2.1 | 2.7 | · | 2.3 | 2.4 | 2.1 | · | 1.9 | |
| Quick Ratio | 1.5 | 1.5 | · | 1.5 | 1.4 | 1.5 | · | 1.3 | 1.5 | 1.9 | · | 1.5 | 1.5 | 1.4 | · | 1.3 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | 16.0 | 14.1 | · | 12.9 | 10.3 | 13.4 | · | 15.1 | 18.1 | 17.5 | · | 5.5 | 16.0 | 17.0 | · | 21.6 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
Valoración (TTM) 17
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7.04B | $6.88B | · | $6.67B | $6.50B | $6.49B | · | $6.48B | $6.62B | $6.80B | · | $6.86B | $6.80B | $6.75B | · | $6.58B | |
| Net Income TTM | $1.20B | $1.17B | · | $1.15B | $1.12B | $1.26B | · | $1.05B | $1.07B | $1.11B | · | $1.09B | $1.26B | $1.24B | · | $1.15B | |
| Market Cap | $32.61B | $37.84B | · | $32.56B | $30.55B | $43.22B | · | $40.66B | $39.96B | $38.12B | · | $35.68B | $39.95B | $45.02B | · | $39.69B | |
| Enterprise Value | $31.11B | $36.38B | · | $31.08B | $29.21B | $41.77B | · | $39.67B | $38.71B | · | · | $34.40B | $38.78B | $44.00B | · | $38.80B | |
| P/E | 27.5 | 32.6 | · | 28.6 | 27.7 | 35.2 | · | 39.5 | 37.8 | 34.5 | · | 33.0 | 32.1 | 36.8 | · | 35.3 | |
| P/S | 4.6 | 5.5 | · | 4.9 | 4.7 | 6.7 | · | 6.3 | 6.0 | 5.6 | · | 5.2 | 5.9 | 6.7 | · | 6.0 | |
| P/B | 4.6 | 5.5 | · | 5.1 | 5.0 | 7.2 | · | 6.9 | 6.4 | 6.2 | · | 6.4 | 6.9 | 8.0 | · | 7.8 | |
| P / Tangible Book | 14.6 | 18.9 | · | 22.8 | 26.2 | 39.9 | · | 26.3 | 21.8 | 21.4 | · | 33.3 | 39.8 | 55.2 | · | 135.0 | |
| P / Cash Flow | · | 141.2 | · | · | · | 100.3 | · | · | · | 78.6 | · | · | · | 152.1 | · | · | |
| P / FCF | · | 216.2 | · | · | · | 129.4 | · | · | · | 96.5 | · | · | · | 204.6 | · | · | |
| EV / EBITDA | 78.0 | 86.6 | · | 86.3 | 97.4 | 93.2 | · | 119.1 | 106.6 | · | · | 258.7 | 101.2 | 89.3 | · | 94.4 | |
| EV / FCF | · | 207.9 | · | · | · | 125.1 | · | · | · | · | · | · | · | 200.0 | · | · | |
| EV / Revenue | 4.4 | 5.3 | · | 4.7 | 4.5 | 6.4 | · | 6.1 | 5.8 | · | · | 5.0 | 5.7 | 6.5 | · | 5.9 | |
| Dividend Yield | 0.87% | 0.75% | · | 0.86% | 0.91% | 0.64% | · | 0.67% | 0.68% | 0.70% | · | 0.73% | 0.65% | 0.57% | · | 0.62% | |
| Earnings Yield | 3.6% | 3.1% | · | 3.5% | 3.6% | 2.8% | · | 2.5% | 2.6% | 2.9% | · | 3.0% | 3.1% | 2.7% | · | 2.8% | |
| Payout Ratio | 21.2% | 23.6% | · | 21.1% | 32.6% | 22.3% | · | 24.1% | 22.4% | 19.8% | · | 59.5% | 21.9% | 19.0% | · | 18.8% | |
| Annual Payout | $285M | $284M | · | $280M | $278M | $277M | · | $272M | $270M | $268M | · | $261M | $258M | $255M | · | $247M |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Ingresos | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| Margen Operativo % | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% |
| Beneficio neto | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| EPS Diluido | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
Balance general
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Ratio corriente | 2.0 | 2.1 | 2.6 | 2.0 | 2.2 |
| Ratio Rápido | 1.4 | 1.4 | 1.8 | 1.3 | 1.6 |
Flujo de Efectivo
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 1 217 declarantes · $26.2B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 151 (+31 vs trimestre anterior) | 76 (-76 vs trimestre anterior) | 431 (+50 vs trimestre anterior) | 339 (-36 vs trimestre anterior) | +53.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4 259 623 862 | 31 304 651 | 16,26% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 450 695 036 | 18 449 861 | 9,36% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 918 389 438 | 14 442 441 | 7,32% | Acciones |
| STATE STREET CORP | $1 710 658 167 | 12 854 230 | 6,53% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $978 381 680 | 7 365 668 | 3,74% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $913 419 841 | 6 876 608 | 3,49% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $881 928 971 | 6 669 587 | 3,37% | Acciones |
| Pictet Asset Management Holding SA | $596 979 330 | 4 494 311 | 2,28% | Acciones |
| NORGES BANK | $513 991 530 | 3 869 544 | 1,96% | Acciones |
| FMR LLC | $496 375 681 | 3 736 924 | 1,89% | Acciones |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $367 735 737 | 2 768 469 | 1,40% | Acciones |
| Troy Asset Management Ltd | $355 539 021 | 2 676 647 | 1,36% | Acciones |
| GOLDMAN SACHS GROUP INC | $301 597 289 | 2 270 551 | 1,15% | Acciones |
| FIRST TRUST ADVISORS LP | $276 230 248 | 2 079 578 | 1,05% | Acciones |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $261 614 131 | 1 969 541 | 1,00% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $259 427 413 | 1 953 078 | 0,99% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $256 612 683 | 1 931 888 | 0,98% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $245 065 240 | 1 844 954 | 0,94% | Acciones |
| Impax Asset Management Group plc | $222 484 548 | 1 674 957 | 0,85% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $210 722 973 | 1 586 411 | 0,80% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $192 780 430 | 1 451 332 | 0,74% | Acciones |
| Qube Research & Technologies Ltd | $188 002 734 | 1 415 364 | 0,72% | Acciones |
| Candriam S.C.A. | $179 443 631 | 1 352 228 | 0,69% | Acciones |
| PRIMECAP MANAGEMENT CO/CA/ | $176 318 012 | 1 327 396 | 0,67% | Acciones |
| Bank of New York Mellon Corp | $175 956 447 | 1 324 674 | 0,67% | Acciones |
| Findlay Park Partners LLP | $174 281 328 | 1 312 063 | 0,67% | Acciones |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $170 987 393 | 1 287 265 | 0,65% | Acciones |
| VAN ECK ASSOCIATES CORP | $163 847 133 | 1 233 510 | 0,63% | Acciones |
| CITADEL ADVISORS LLC | $141 805 854 | 1 067 574 | 0,54% | Acciones |
| JUPITER ASSET MANAGEMENT LTD | $137 850 416 | 1 046 214 | 0,53% | Acciones |
| Robeco Schweiz AG | $133 837 515 | 1 007 585 | 0,51% | Acciones |
| TD Asset Management Inc | $132 416 102 | 996 884 | 0,51% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $125 377 572 | 943 900 | 0,48% | Acciones |
| BlackRock, Inc. | $116 504 263 | 877 093 | 0,44% | Acciones |
| Quantinno Capital Management LP | $115 638 237 | 870 573 | 0,44% | Acciones |
| Alyeska Investment Group, L.P. | $108 252 598 | 814 971 | 0,41% | Acciones |
| Swiss National Bank | $105 892 076 | 797 200 | 0,40% | Acciones |
| Scharf Investments, LLC | $100 176 558 | 754 161 | 0,38% | Acciones |
| Legal & General Group Plc | $98 122 318 | 738 706 | 0,37% | Acciones |
| Liontrust Investment Partners LLP | $96 037 390 | 705 794 | 0,37% | Acciones |
| M&G PLC | $95 397 309 | 717 273 | 0,36% | Acciones |
| Madison Investment Advisors, LLC | $94 050 693 | 700 094 | 0,36% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $92 358 027 | 695 310 | 0,35% | Acciones |
| Freestone Grove Partners LP | $91 081 398 | 685 699 | 0,35% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $90 900 351 | 684 336 | 0,35% | Acciones |
| SUMMITRY LLC | $88 508 881 | 666 332 | 0,34% | Acciones |
| BANK OF AMERICA CORP /DE/ | $87 994 562 | 662 460 | 0,34% | Acciones |
| AMERIPRISE FINANCIAL INC | $87 419 975 | 658 029 | 0,33% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $85 742 481 | 752 259 | 0,33% | Acciones |
| LAZARD ASSET MANAGEMENT LLC | $85 180 425 | 641 274 | 0,33% | Acciones |
| Madison Asset Management, LLC | $83 917 028 | 631 763 | 0,32% | Acciones |
| JENNISON ASSOCIATES LLC | $82 524 356 | 621 278 | 0,32% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $81 741 191 | 615 382 | 0,31% | Acciones |
| Vanguard Global Advisers, LLC | $80 906 886 | 609 101 | 0,31% | Acciones |
| PARNASSUS INVESTMENTS, LLC | $80 640 827 | 607 098 | 0,31% | Acciones |
| California Public Employees Retirement System | $79 884 892 | 601 407 | 0,30% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $75 494 859 | 568 162 | 0,29% | Acciones |
| Fenimore Asset Management Inc | $74 567 504 | 561 375 | 0,28% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $72 868 280 | 548 583 | 0,28% | Acciones |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $72 747 936 | 547 677 | 0,28% | Acciones |
| Harvest Portfolios Group Inc. | $70 685 352 | 532 149 | 0,27% | Acciones |
| JANE STREET GROUP, LLC | $69 842 014 | 525 800 | 0,27% | Opción de venta |
| Select Equity Group, L.P. | $68 419 936 | 515 094 | 0,26% | Acciones |
| RHUMBLINE ADVISERS | $66 522 113 | 500 807 | 0,25% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $63 471 621 | 477 841 | 0,24% | Acciones |
| National Pension Service | $62 363 818 | 469 501 | 0,24% | Acciones |
| Squarepoint Ops LLC | $61 937 832 | 466 294 | 0,24% | Acciones |
| BARCLAYS PLC | $61 183 224 | 460 613 | 0,23% | Acciones |
| EARNEST PARTNERS LLC | $59 928 911 | 451 170 | 0,23% | Acciones |
| BANK OF NOVA SCOTIA | $58 538 579 | 440 703 | 0,22% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $57 724 332 | 434 573 | 0,22% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $57 355 994 | 431 800 | 0,22% | Opción de compra |
| DAVENPORT & Co LLC | $57 354 874 | 431 792 | 0,22% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49 992 426 | 438 607 | 0,19% | Acciones |
| D. E. Shaw & Co., Inc. | $47 442 758 | 357 169 | 0,18% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $46 586 802 | 350 725 | 0,18% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $43 801 225 | 329 754 | 0,17% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $43 116 220 | 324 597 | 0,16% | Acciones |
| CITADEL ADVISORS LLC | $42 784 543 | 322 100 | 0,16% | Opción de compra |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42 660 480 | 321 166 | 0,16% | Acciones |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $41 663 724 | 313 662 | 0,16% | Acciones |
| Swedbank AB | $39 972 666 | 300 931 | 0,15% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39 596 623 | 298 100 | 0,15% | Opción de venta |
| Robeco Institutional Asset Management B.V. | $39 088 283 | 294 273 | 0,15% | Acciones |
| Northwest & Ethical Investments L.P. | $35 746 445 | 269 114 | 0,14% | Acciones |
| Gotham Asset Management, LLC | $34 062 261 | 256 435 | 0,13% | Acciones |
| AVIVA PLC | $32 455 417 | 244 338 | 0,12% | Acciones |
| Corient Private Wealth LP | $32 351 707 | 243 555 | 0,12% | Acciones |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $31 475 662 | 236 962 | 0,12% | Acciones |
| Aberdeen Group plc | $31 361 030 | 236 099 | 0,12% | Acciones |
| Polar Capital Holdings Plc | $28 652 361 | 215 707 | 0,11% | Acciones |
| ASSETMARK, INC | $28 532 974 | 214 808 | 0,11% | Acciones |
| Eurizon Capital SGR S.p.A. | $27 472 791 | 206 818 | 0,10% | Acciones |
| DANSKE BANK A/S | $26 955 989 | 202 936 | 0,10% | Acciones |
| DKRT Investments Corp. | $26 566 000 | 200 000 | 0,10% | Acciones |
| HSBC HOLDINGS PLC | $26 124 912 | 198 006 | 0,10% | Acciones |
| ROYAL BANK OF CANADA | $25 054 000 | 188 614 | 0,10% | Acciones |
| Epoch Investment Partners, Inc. | $24 780 233 | 186 556 | 0,09% | Acciones |
| STRS OHIO | $24 668 258 | 185 713 | 0,09% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $24 547 914 | 184 807 | 0,09% | Acciones |
Informantes de la empresa 65 insiders · 39 directivos · 23 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| MCDONNELL PADRAIG | President and CEO | 3 de junio de 2026 F | 65 842 | 0 | 3 | $-2 253 752 |
| Michael R. Mcmullen | CEO and President | 8 de marzo de 2024 S | 253 909 | 0 | 0 | $0 |
| William P Sullivan | CEO | 1 de diciembre de 2014 S | 458 167 | 0 | 0 | $0 |
| Adam Stewart Elinoff | Senior Vice President and CFO | 18 de noviembre de 2025 A | 11 726 | 0 | 0 | $0 |
| Robert W. Mcmahon | Sr. VP and CFO | 22 de mayo de 2025 F | 168 754 | 0 | 0 | $0 |
| Didier Hirsch | Sr. VP and CFO | 7 de diciembre de 2017 F | 184 432 | 0 | 0 | $0 |
| Adrian T Dillon | EVP, Finance & Admin., CFO | 30 de marzo de 2010 M | 129 925 | 0 | 0 | $0 |
| Jonah Prevost Kirkwood | Senior Vice President | 26 de junio de 2026 F | 14 108 | 0 | 0 | $0 |
| Michael Steven Buckner | Senior Vice President | 19 de mayo de 2026 A | 8 887 | 0 | 0 | $0 |
| Simon May | Senior Vice President | 8 de mayo de 2026 F | 14 015 | 0 | 0 | $0 |
| Meghan Henson | Senior Vice President | 31 de marzo de 2026 F | 6 890 | 0 | 0 | $0 |
| Angelica Riemann | Senior Vice President | 27 de febrero de 2026 F | 26 535 | 0 | 0 | $0 |
| Jianmiao Mike Zhang | Senior Vice President | 26 de noviembre de 2025 F | 11 639 | 0 | 0 | $0 |
| Rodney Gonsalves | V.P., Corporate Controller | 26 de noviembre de 2025 G | 0 | 0 | 1 | $-464 970 |
| Bret Dimarco | Senior Vice President | 26 de noviembre de 2025 F | 12 203 | 0 | 0 | $0 |
| Henrik Ancher-Jensen | Sr Vice President | 30 de mayo de 2025 F | 86 426 | 0 | 0 | $0 |
| Philip Binns | Senior Vice President | 19 de noviembre de 2024 A | 10 650 | 0 | 0 | $0 |
| Dominique Grau | Senior Vice President | 26 de septiembre de 2024 S | 46 762 | 0 | 0 | $0 |
| Michael Tang | SVP, General Counsel, and Sec. | 22 de noviembre de 2023 A | 54 872 | 0 | 0 | $0 |
| Samraat S. Raha | Sr. Vice President | 14 de noviembre de 2023 F | 87 196 | 0 | 0 | $0 |
| Jacob Thaysen | Sr. Vice President | 1 de diciembre de 2022 S | 84 464 | 0 | 0 | $0 |
| Mark Doak | Sr. Vice President | 3 de marzo de 2020 S | 135 678 | 0 | 0 | $0 |
| Patrick Kaltenbach | Sr Vice President | 29 de marzo de 2018 M | 68 547 | 0 | 0 | $0 |
| Marie Oh Huber | Sr VP, General Counsel & Sec. | 3 de marzo de 2015 M | 44 772 | 0 | 0 | $0 |
| Solange Glaize | VP, Chief Accounting Officer | 20 de febrero de 2015 M | 5 370 | 0 | 0 | $0 |
| Fred Strohmeier | Senior Vice President | 19 de noviembre de 2014 A | 27 496 | 0 | 0 | $0 |
| Guy Sene | Senior Vice President | 2 de septiembre de 2014 M | 32 713 | 0 | 0 | $0 |
| Jean Halloran | Senior Vice President | 17 de junio de 2014 M | 74 962 | 0 | 0 | $0 |
| Ronald S. Nersesian | Executive Vice President | 21 de noviembre de 2013 M | 102 821 | 0 | 0 | $0 |
| Lars Holmkvist | Senior Vice President | 20 de noviembre de 2013 A | — | 0 | 0 | $0 |
| Nicolas H Roelofs PHD | Senior Vice President | 28 de marzo de 2013 M | 84 136 | 0 | 0 | $0 |
| Saleem N. Odeh | Vice President | 18 de noviembre de 2009 A | 22 540 | 0 | 0 | $0 |
| Lonnie G. Justice | Vice President | 18 de noviembre de 2009 A | 32 742 | 0 | 0 | $0 |
| Soon Chai Gooi | Vice President | 18 de noviembre de 2009 A | 27 285 | 0 | 0 | $0 |
| David S Churchill | Vice President | 18 de noviembre de 2009 F | 25 602 | 0 | 0 | $0 |
| Chris Van Ingen | Senior Vice President | 31 de octubre de 2007 J | 62 083 | 0 | 0 | $0 |
| Thomas White | Senior Vice President | 28 de abril de 2006 A | 16 331 | 0 | 0 | $0 |
| Jack P Trautman | Senior Vice President | 29 de abril de 2005 A | 12 343 | 0 | 0 | $0 |
| Dick M Chang | Senior Vice President | 29 de abril de 2005 A | 7 174 | 0 | 0 | $0 |
| Mikael Dolsten | Consejero | 29 de mayo de 2026 S | 5 548 | 0 | 2 | $-606 178 |
| Pascal Soriot | Consejero | 19 de marzo de 2026 F | 2 683 | 0 | 0 | $0 |
| Mala Anand | Consejero | 19 de marzo de 2026 A | 16 705 | 0 | 0 | $0 |
| Daniel K Podolsky | Consejero | 19 de marzo de 2026 A | 38 180 | 0 | 0 | $0 |
| Sue H. Rataj | Consejero | 19 de marzo de 2026 A | 23 617 | 0 | 0 | $0 |
| Judy L Brown | Consejero | 19 de marzo de 2026 A | 3 835 | 0 | 0 | $0 |
| Dow R Wilson | Consejero | 19 de marzo de 2026 A | 20 369 | 0 | 0 | $0 |
| Boon Hwee Koh | Consejero | 19 de marzo de 2026 F | 63 184 | 0 | 0 | $0 |
| Otis W Brawley | Consejero | 19 de marzo de 2026 A | 13 874 | 0 | 0 | $0 |
| George A Scangos | Consejero | 19 de marzo de 2026 A | 23 857 | 0 | 0 | $0 |
| Heidi Kunz | Consejero | 14 de marzo de 2025 A | 58 851 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. | 16 de abril de 2007 | — | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 180 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PHO · Invesco Exchange-Traded Fund Trust | 3,90% | 559 512 SH | 8 de agosto de 2026 | Diario |
| KAT · Advisors Series Trust | 3,04% | 179 660 NS | 31 de marzo de 2026 | N-PORT |
| GKAT · Advisors Series Trust | 3,00% | 39 208 NS | 31 de marzo de 2026 | N-PORT |
| PIO · Invesco Exchange-Traded Fund Trust … | 2,89% | 56 131 SH | 8 de agosto de 2026 | Diario |
| GDOC · Goldman Sachs ETF Trust | 2,77% | 4 105 NS | 31 de mayo de 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1,89% | 24 916 SH | 8 de agosto de 2026 | Diario |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,68% | 90 084 SH | 8 de agosto de 2026 | Diario |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,62% | 7 491 NS | 30 de abril de 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 1,27% | 3 201 NS | 31 de mayo de 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1,18% | 461 NS | 30 de abril de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,88% | 66 406 NS | 30 de abril de 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,82% | 2 162 223 SH | 8 de agosto de 2026 | Diario |
| JOET · Virtus ETF Trust II | 0,79% | 16 177 NS | 30 de abril de 2026 | N-PORT |
| IYH · iShares Trust | 0,65% | 169 194 SH | 8 de agosto de 2026 | Diario |
| KRMA · Global X Funds | 0,58% | 5 164 NS | 31 de mayo de 2026 | N-PORT |
| LCLG · Advisors Series Trust | 0,57% | 5 020 NS | 30 de abril de 2026 | N-PORT |
| RXL · ProShares Trust | 0,55% | 2 949 NS | 31 de mayo de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,55% | 849 670 SH | 8 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,53% | 130 688 NS | 30 de abril de 2026 | N-PORT |
| GSY · Invesco Actively Managed Exchange-T… | 0,52% | 20 000 000 | 8 de agosto de 2026 | Diario |
| IXJ · iShares Trust | 0,50% | 148 250 SH | 8 de agosto de 2026 | Diario |
| NULC · Nushares ETF Trust | 0,50% | 2 455 NS | 30 de abril de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,47% | 5 640 NS | 30 de abril de 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,44% | 41 201 NS | 30 de abril de 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,40% | 11 883 NS | 31 de mayo de 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,39% | 1 301 NS | 30 de abril de 2026 | N-PORT |
| IWS · iShares Trust | 0,38% | 426 163 SH | 8 de agosto de 2026 | Diario |
| GNOM · Global X Funds | 0,38% | 1 553 NS | 31 de mayo de 2026 | N-PORT |
| ACGR · AMERICAN CENTURY ETF TRUST | 0,37% | 310 NS | 31 de mayo de 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,36% | 6 116 302 SH | 8 de agosto de 2026 | Diario |
| SFGV · EA Series Trust | 0,34% | 28 465 NS | 29 de mayo de 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0,34% | 7 696 NS | 31 de mayo de 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 0,31% | 1 211 NS | 30 de abril de 2026 | N-PORT |
| IWR · iShares Trust | 0,29% | 1 149 977 SH | 8 de agosto de 2026 | Diario |
| IMCV · iShares Trust | 0,28% | 23 013 SH | 8 de agosto de 2026 | Diario |
| IMCB · iShares Trust | 0,27% | 32 787 SH | 8 de agosto de 2026 | Diario |
| NUMV · Nushares ETF Trust | 0,27% | 10 213 NS | 30 de abril de 2026 | N-PORT |
| SUSA · iShares Trust | 0,27% | 78 831 SH | 8 de agosto de 2026 | Diario |
| IMCG · iShares Trust | 0,27% | 76 769 SH | 8 de agosto de 2026 | Diario |
| DFLV · Dimensional ETF Trust | 0,25% | 129 056 NS | 30 de abril de 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 7 180 SH | 8 de agosto de 2026 | Diario |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 8 663 NS | 30 de abril de 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,23% | 30 784 SH | 8 de agosto de 2026 | Diario |
| XT · iShares Trust | 0,23% | 62 639 SH | 8 de agosto de 2026 | Diario |
| GSEW · Goldman Sachs ETF Trust | 0,22% | 29 372 NS | 31 de mayo de 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,22% | 3 514 NS | 31 de mayo de 2026 | N-PORT |
| XOEF · iShares Trust | 0,22% | 355 SH | 8 de agosto de 2026 | Diario |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 1 410 724 SH | 8 de agosto de 2026 | Diario |
| NULV · Nushares ETF Trust | 0,19% | 34 471 NS | 30 de abril de 2026 | N-PORT |
| SGLC · RBB Fund, Inc. | 0,19% | 2 753 NS | 31 de mayo de 2026 | N-PORT |